SCHEMBL25324910

SCHEMBL25324910

Cn1cc(Br)c(-c2ccc(OC(F)F)nc2)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAT2A P31153 2/20 0.37
RET P07949 1/20 0.34
JMJD6 Q6NYC1 1/20 0.33
FLT3 P36888 1/20 0.33
SYK P43405 1/20 0.33
KCNH2 Q12809 2/20 0.33
GRIN2B Q13224 2/20 0.33
DAO P14920 1/20 0.33
PDE4A P27815 1/20 0.32
PDE4B Q07343 1/20 0.32
PDE4C Q08493 1/20 0.32
PDE4D Q08499 1/20 0.32
CSNK1D P48730 2/20 0.32
MAPK11 Q15759 2/20 0.32
MAPK14 Q16539 2/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
F2RL3 Q96RI0 1/20 0.32
PIK3CD O00329 1/20 0.31
PIK3CA P42336 1/20 0.31
PIK3CB P42338 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30509539 1.00 MAT2A (0.37) MAT2ARETJMJD6FLT3SYK
SCHEMBL13874180 0.83 JMJD6 (0.45) JMJD6
SCHEMBL30509471 0.77 KDM5B (0.39) RETGRIN2BCSNK1DMAPK11MAPK14
SCHEMBL25324264 0.77 KDM5B (0.39) RETGRIN2BCSNK1DMAPK11MAPK14
SCHEMBL30509536 0.75 HPGDS (0.40) PDE4DCSNK1DMAPK11MAPK14L3MBTL1
SCHEMBL15885703 0.75 HPGDS (0.40) PDE4DCSNK1DMAPK11MAPK14L3MBTL1
SCHEMBL15885979 0.75 CHRNB2 (0.41) L3MBTL1PIK3CDALDH1A1
SCHEMBL25323581 0.73 CSNK1D (0.34) MAT2AFLT3SYKKCNH2GRIN2B
SCHEMBL25323510 0.72 CSNK1D (0.66) CSNK1DMAPK11MAPK14
SCHEMBL30509372 0.72 CSNK1D (0.66) CSNK1DMAPK11MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230339900-A1 CASEIN KINASE 1 DELTA MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2023-10-26 US disclosed
US-20230339900-A1 CASEIN KINASE 1 DELTA MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2023-10-26 US disclosed
US-20230339900-A1 CASEIN KINASE 1 DELTA MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2023-10-26 US disclosed
EP-4214199-A1 CASEIN KINASE 1 DELTA MODULATORS JANSSEN Pharmaceutica NV (BE) 2023-07-26 EP disclosed
CN-116490503-A Casein kinase 1 delta modulators 詹森药业有限公司 2023-07-25 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230339900-A1 CASEIN KINASE 1 DELTA MODULATORS CSNK1D, CSNK1A1, CSNK2A1 MAT2A 4245/4885RET 535/4885JMJD6 3200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.